Mercury Laboratories Ltd.
Snapshot View

View in App

Prices View details >>

559.85 +26.65 ▲5.0%

29 March 2023, 04:01:00 PM
Volume: 511

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.mercurylabs.com
Market Cap 67.18 Cr.
Enterprise Value(EV) 65.24 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 51.40 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 10.89 Trailing Twelve Months Ending 2022-12
Industry PE 32.17 Trailing Twelve Months Ending 2022-12
Book Value / Share 376.11 Trailing Twelve Months Ending 2022-12
Price to Book Value 1.49 Calculated using Price: 559.85
Dividend Yield 0.63 Period Ending 2022-03
No. of Shares Subscribed 0.12 Cr. 1,200,000 Shares
FaceValue 10
Company Profile
The company is engaged in manufacturing of pharmaceutical products. It is mainly dedicated to Mother and child care products.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+5.00%
1 Week
-0.36%
1 Month
-8.56%
3 Month
-26.82%
6 Month
-6.69%
1 Year
+13.27%
2 Year
-8.97%
5 Year
+43.55%
10 Year

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 23.18 19.75 19.62 11.67 7.92 10.26 10.59 15.50 9.55
Return on Capital Employed (%) 26.27 21.32 21.58 18.93 9.89 13.77 13.25 20.56 12.53
Return on Assets (%) 8.82 8.01 8.81 5.54 3.92 5.20 5.68 8.77 5.73

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 15 18 22 24 26 29 32 37 40 45
Non Curr. Liab. 5 4 4 10 12 11 9 10 9 6
Curr. Liab. 19 21 20 17 13 17 15 19 14 18
Minority Int.
Equity & Liab. 40 43 47 51 52 57 56 65 63 69
Non Curr. Assets 20 20 19 20 22 25 25 28 27 26
Curr. Assets 21 23 28 31 30 32 32 38 36 43
Misc. Exp. not W/O
Total Assets 40 43 47 51 52 57 56 65 63 69

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 41 41 48 48 52 56 57 69 58 69
Other Income 1 1 1 0 0 1 1 1 1 2
Total Income 42 42 48 48 52 57 58 69 59 71
Total Expenditure -35 -35 -41 -41 -47 -50 -51 -59 -51 -60
PBIDT 7 7 7 7 5 7 7 10 8 11
Interest -1 -1 -1 -1 -1 -1 -1 -1 0 0
Depreciation -1 -1 -1 -1 -1 -2 -2 -2 -2 -2
Taxation -2 -1 -1 -2 0 -1 -1 -3 -1 -2
Exceptional Items 0 0 0
PAT 3 3 4 3 2 3 3 5 4 6
Adjusted EPS 27 28 33 23 17 24 27 44 31 51

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 7 3 3 0 2 5 5 5 8 5
Cash Fr. Inv. -12 -2 -2 0 -2 -4 -5 -1 -5 -2
Cash Fr. Finan. 5 -1 -2 0 0 1 -3 -3 -1 -1
Net Change 1 0 0 0 0 2 -2 1 2 2
Cash & Cash Eqvt 1 1 1 1 1 4 1 3 5 7

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 73.62 73.66 73.66 73.66 73.66 73.66 73.66 73.66 73.66
Public 26.38 26.34 26.34 26.34 26.34 26.34 26.34 26.34 26.34
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Sat, 25 Mar 2023
Closure of Trading Window
Intimation regarding Closure of Trading Window_Mercury Laboratories Limited
Tue, 21 Mar 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding issue of Letter of Confirmation in lieu Duplicate Share Certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirement) Regulation 2015
Wed, 15 Feb 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of Newspaper publication under Regulation 47 of SEBI (LODR) Regulation 2015_Mercury Laboratories Limited

Technical Scans View Details >>

Wed, 29 Mar 2023
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 237,702.12 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. 76,011.65 4,564.50 +0.8%
Divi's Laboratories Ltd. 74,827.63 2,818.70 +0.5%
Cipla Ltd. 71,662.87 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. 62,756.97 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. 52,113.83 1,554.65 +0.7%
Zydus Lifesciences Ltd. 49,628.37 490.30 +1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 56.44 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.86 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 31.22 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 27.16 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 82.20 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 63.32 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 24.08 490.30 +1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.36 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.37 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 5.66 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 3.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 9.90 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 7.53 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.77 490.30 +1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 0.04 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 490.30 +1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 490.30 +1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 490.30 +1.2%

FAQ's On Mercury Laboratories Ltd.

What is Mercury Laboratories share price?
Can I buy Mercury Laboratories shares now?
What is the Dividend Yield of Mercury Laboratories?
What is the Market Cap of Mercury Laboratories?
What are the key metrics to analyse Mercury Laboratories?
What is the 52 Week High and Low of Mercury Laboratories?
What is the trend of Mercury Laboratories share price?